$NVCR NovoCure Ltd Insider Trading Week 18/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd in week 18/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Option Exercise | A | 47.56 | 33,052 | 1,571,953 | 33,052 | |
| May 10 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 47.56 | 36,650 | 1,743,074 | 36,650 | |
| May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.56 | 35,000 | 1,664,600 | 35,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | A | 47.56 | 115,060 | 5,472,254 | 115,060 | |
| May 10 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.37 | 31,460 | 1,490,386 | 896,463 | 927.9 K to 896.5 K (-3.39 %) |
| May 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | A | 47.56 | 20,000 | 951,200 | 20,000 | |
| May 10 2019 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | A | 47.56 | 91,515 | 4,352,453 | 91,515 | |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 293,839 | |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 352,607 | |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 47.62 | 58,768 | 2,798,532 | 927,923 | 869.2 K to 927.9 K (+6.76 %) |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.52 | 32,218 | 1,531,032 | 869,155 | 901.4 K to 869.2 K (-3.57 %) |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 48.92 | 58,768 | 2,874,931 | 901,373 | 842.6 K to 901.4 K (+6.97 %) |
| May 09 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 47.67 | 32,098 | 1,530,112 | 842,605 | 874.7 K to 842.6 K (-3.67 %) |
| May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 411,375 | |
| May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 48.89 | 58,768 | 2,873,168 | 874,703 | 815.9 K to 874.7 K (+7.20 %) |
| May 07 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 48.07 | 29,038 | 1,395,915 | 815,935 | 845 K to 815.9 K (-3.44 %) |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 470,143 | |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Option Exercise | M | 0.00 | 58,768 | 0 | 528,911 | |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 44.60 | 58,768 | 2,621,053 | 844,973 | 786.2 K to 845 K (+7.47 %) |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 45.21 | 29,966 | 1,354,643 | 786,205 | 816.2 K to 786.2 K (-3.67 %) |
| May 06 2019 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Buy | M | 43.28 | 58,768 | 2,543,479 | 816,171 | 757.4 K to 816.2 K (+7.76 %) |